<?xml version='1.0' encoding='utf-8'?>
<document id="27335682"><sentence text="Inhibitory effects of chemotherapeutics on human organic anion transporter hOAT4." /><sentence text="Human organic anion transporter 4 (hOAT4) belongs to a family of organic anion transporters which play critical roles in the body disposition of clinically important drugs" /><sentence text=" hOAT4 is expressed in the kidney and placenta" /><sentence text=" In the current study, we examined the inhibitory effects of 101 anticancer drugs from a clinical drug library on hOAT4 transport activity" /><sentence text=" The studies were carried out in hOAT4-expressing human kidney HEK-293 cells and human placenta BeWo cells" /><sentence text=" Among these drugs, only chlorambucil and cabazitaxel demonstrated more than 50% cis-inhibitory effect on hOAT4-mediated uptake of (3)H-labeled estrone sulfate, a prototypical substrate for the transporter"><entity charOffset="25-37" id="DDI-PubMed.27335682.s6.e0" text="chlorambucil" /><entity charOffset="42-53" id="DDI-PubMed.27335682.s6.e1" text="cabazitaxel" /><entity charOffset="144-159" id="DDI-PubMed.27335682.s6.e2" text="estrone sulfate" /><pair ddi="false" e1="DDI-PubMed.27335682.s6.e0" e2="DDI-PubMed.27335682.s6.e0" /><pair ddi="false" e1="DDI-PubMed.27335682.s6.e0" e2="DDI-PubMed.27335682.s6.e1" /><pair ddi="false" e1="DDI-PubMed.27335682.s6.e0" e2="DDI-PubMed.27335682.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27335682.s6.e1" e2="DDI-PubMed.27335682.s6.e1" /><pair ddi="false" e1="DDI-PubMed.27335682.s6.e1" e2="DDI-PubMed.27335682.s6.e2" /></sentence><sentence text=" The IC50 values for chlorambucil and cabazitaxel were 44"><entity charOffset="21-33" id="DDI-PubMed.27335682.s7.e0" text="chlorambucil" /><entity charOffset="38-49" id="DDI-PubMed.27335682.s7.e1" text="cabazitaxel" /><pair ddi="false" e1="DDI-PubMed.27335682.s7.e0" e2="DDI-PubMed.27335682.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27335682.s7.e0" e2="DDI-PubMed.27335682.s7.e1" /></sentence><sentence text="28 and 3" /><sentence text="5 µM respectively" /><sentence text=" Dixon plot analysis revealed that inhibition by chlorambucil was competitive with a Ki = 55"><entity charOffset="49-61" id="DDI-PubMed.27335682.s10.e0" text="chlorambucil" /></sentence><sentence text="73 µM whereas inhibition by cabazitaxel was non-competitive with a Ki = 1"><entity charOffset="28-39" id="DDI-PubMed.27335682.s11.e0" text="cabazitaxel" /></sentence><sentence text="78 µM" /><sentence text=" Our results demonstrated that chlorambucil and cabazitaxel were inhibitors of hOAT4"><entity charOffset="31-43" id="DDI-PubMed.27335682.s13.e0" text="chlorambucil" /><entity charOffset="48-59" id="DDI-PubMed.27335682.s13.e1" text="cabazitaxel" /><pair ddi="false" e1="DDI-PubMed.27335682.s13.e0" e2="DDI-PubMed.27335682.s13.e0" /><pair ddi="false" e1="DDI-PubMed.27335682.s13.e0" e2="DDI-PubMed.27335682.s13.e1" /></sentence><sentence text=" Furthermore, by comparing our data with clinically relevant exposures of these drugs, we conclude that the propensity for chlorambucil and cabazitaxel to cause drug-drug interaction through inhibition of hOAT4 is low"><entity charOffset="123-135" id="DDI-PubMed.27335682.s14.e0" text="chlorambucil" /><entity charOffset="140-151" id="DDI-PubMed.27335682.s14.e1" text="cabazitaxel" /><pair ddi="false" e1="DDI-PubMed.27335682.s14.e0" e2="DDI-PubMed.27335682.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27335682.s14.e0" e2="DDI-PubMed.27335682.s14.e1" /></sentence><sentence text=" " /></document>